Article info

Download PDFPDF

Effectiveness and safety of intravitreal aflibercept in patients with wet age-related macular degeneration treated in routine clinical practices across France: 12-month outcomes of the RAINBOW study

Authors

  1. Correspondence to Dr Michel Weber; weber.michel{at}bbox.fr
View Full Text

Citation

Weber M, Velasque L, Coscas F on behalf of the RAINBOW study investigators, et al
Effectiveness and safety of intravitreal aflibercept in patients with wet age-related macular degeneration treated in routine clinical practices across France: 12-month outcomes of the RAINBOW study

Publication history

  • Received August 21, 2017
  • Revised March 26, 2018
  • Accepted July 1, 2018
  • First published April 9, 2019.
Online issue publication 
April 09, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.